This trial is evaluating whether Motivational Interviewing-Cognitive Behavioral Therapy Ketogenic Nutrition Adherence Program will improve 3 primary outcomes and 1 secondary outcome in patients with Adherence, Patient. Measurement will happen over the course of 5 weeks.
This trial requires 40 total participants across 2 different treatment groups
This trial involves 2 different treatments. Motivational Interviewing-Cognitive Behavioral Therapy Ketogenic Nutrition Adherence Program is the primary treatment being studied. Participants will all receive the same treatment. There is no placebo group. The treatments being tested are not being studied for commercial purposes.
In the last 4 years, there are more individuals diagnosed with dementia than in the past. Cognitive decline leads to impaired long-term memory and attention. This may be a clue indicative of cognitive decline.
Cognitive decline, a combination of executive, visual and spatial cognition, is a predictor of future disability in this population of community-living adults, especially in patients with concurrent disease. Results from a recent paper warrant further investigation into the relationship of these deficits to the pathology of Alzheimer's disease.
Cognitive decline is a natural part of normal aging, rather than a disease. If diagnosed and treated correctly, people with the syndrome can lead full and active lives, with much of it in the spirit of adventure despite old age. Therefore, the most that can be expected is to be able to mitigate memory loss and slowing. The best evidence for this was that cognitive impairment and declines in abilities after age 40 were associated, not worsened by, a higher risk of mortality. Because the cognitive symptoms were common and more common in older people than in young people, the cognitive effects of cognition can be expected to increase with age in a normal aging population. In the current situation, cognitive decline as a disease state was not supported.
Cognitive decline is often treated through CBT, counseling, medical therapy, counseling, and education support. There is no cure for dementia, so therapy is often focused on symptom management and is highly dependent on individual cases.
At least 6 million Americans are predicted to have declines in one or all aspects of global cognition within the next 10 years. Because the strongest predictor of cognitive decline is subjective memory complaints, efforts to preserve and maintain cognitive function in old age should include memory-specific interventions.
In many people with dementia, there is a progressive loss of memory and thought, and these issues are the main concerns of carers. Because these impairments do not develop when cognition is examined in isolation, it is probable that there is a large part of the brain which can maintain cognitive function. Cognitive change tends to coincide with neurological disease of a peripheral aetiology. This is particularly reflected in the cognitive deficits in vascular dementias.
The motivational interviewing-cognitive behavioral program was well-received by patients and physicians, and it was effective in increasing ketogenic diet adherence. Patients who demonstrated a better sense of meaning of keto had improved ketogenic diet adherence. In a recent study, findings suggest that motivational interviewing-cognitive behavioral therapy may be a useful and affordable intervention for patients with non-adherence to ketogenic diet. Copyright © 2015 John Wiley & Sons, Ltd.
The majority of recent findings to improve cognitive decline relate to the use of exercise and cognition. However, the use of exercise as a specific intervention for cognitive decline is highly understudied and a subject of much needed research.
The ketogenic nutrition adherence program (MAP) had positive short-term and long-term effects. The use of motivational interviewing-cognitive behavioral therapy-based interventions in patients with metabolic disorders, especially those who could be challenging when communicating nutrition recommendations, improves the potential for adherence to nutrition care and may lead to better health outcomes.
Data from a recent study revealed the average age of cognitive decline onset. By focusing on a patient's age of cognitive decline, healthcare practitioners can better understand and treat cognitive impairment.
Results from a recent paper provide valuable information that could help providers use research-based methods to support patients by identifying and addressing barriers to ketogenic diet adherence and improving patients' nutritional self-management skills. If verified in larger trials, our results suggest that this approach would be a valuable addition to the patient education process to improve self-management and ultimately decrease the likelihood to regain weight.